CAJ | 학술논문

目的探讨异丙托溴铵与布地奈德/福莫特罗联合治疗 COPD 稳定期临床效果.方法选择80例慢性阻塞性肺疾病稳定期患者,随机分为观察组和对照组.观察组给予异丙托溴铵与布地奈德/福莫特罗联合治疗,对照组给予布地奈德/福莫特罗联合治疗.观察组治疗前后肺功能改变情况.结果观察组治疗后用力肺活量、第一秒用力呼气容积、第一秒用力呼气量预计值的百分比分别与对照组治疗后比较,差异有统计学意义(P <0.05).结论异丙托溴铵与布地奈德/福莫特罗联合治疗能够显著改善稳定期慢性阻塞性肺疾病患者肺功能,治疗效果显著.
목적탐토이병탁추안여포지내덕/복막특라연합치료 COPD 은정기림상효과.방법선택80례만성조새성폐질병은정기환자,수궤분위관찰조화대조조.관찰조급여이병탁추안여포지내덕/복막특라연합치료,대조조급여포지내덕/복막특라연합치료.관찰조치료전후폐공능개변정황.결과관찰조치료후용력폐활량、제일초용력호기용적、제일초용력호기량예계치적백분비분별여대조조치료후비교,차이유통계학의의(P <0.05).결론이병탁추안여포지내덕/복막특라연합치료능구현저개선은정기만성조새성폐질병환자폐공능,치료효과현저.
Objective To explore the clinical efficacy of ipratropium bromide combined with budesonide/formoterol on stabilization COPD.Methods Eighty cases with stabilization COPD were selected and divided into two groups,observation group and control group. budesonide/formoterol was given to observation group,ipratropium bromide combined with budesonide/formoterol was given to observation group.the lung function was detected befor and after treatment.Results The forced vital capacity, forced expiratory volume in the first second, forced expiratory volume in the first second of predicted percentage in observation group after treatment compared with those in control group,the difference was statistically significant (P<0.05 ).Conclusions Ipratropium bromide combined with budesonide / formoterol can improve the lung function of the patients with stabilization COPD,the clinical efficacy is significant.